Medicine

During a visit to the French pilgrimage site of Lourdes, the Pope declared that medicine must never become a servant of programmed death, in remarks touching on euthanasia and end-of-life care. He framed medical practice as fundamentally oriented toward defending life and comforting the sick rather than hastening their passing, appealing to caregivers gathered at the major Catholic healing shrine.

The Trump administration is retreating from a proposed executive order that would have increased White House control over National Institutes of Health grant decisions. Reporting by Semafor says the plan to tighten oversight of NIH funding appears to be dead after significant pushback from scientists, universities and lawmakers, who warned it would politicise medical research funding decisions.

Stanford Medicine is drawing widespread attention with the claim that the human brain functions as two distinct organs rather than a single one. The announcement was reported by KRON 4 and has generated heavy engagement online. Details of the research, including how the finding was reached and its implications for neuroscience and medicine, were not included in the coverage available.

A debate is unfolding over legal accountability when artificial intelligence systems make errors in medical care. As AI tools move into diagnosis, treatment recommendations and clinical workflows, doctors, hospitals and technology developers are all potential defendants. The core question: does responsibility rest with the physician who followed the algorithm, the hospital that deployed it, or the company that built it. Legal frameworks have not kept pace.

GLP-1 weight-loss drugs such as Ozempic and Wegovy are reshaping sleep medicine, with clinicians reporting improved sleep apnea symptoms in patients losing significant weight and drugmakers seeking apnea indications. Sleep specialists are debating whether medication could reduce reliance on CPAP machines, while researchers caution that long-term effects on sleep disorders remain largely unstudied.

An obesity medicine doctor is addressing the growing trend of taking small, lower-than-prescribed doses of Ozempic, the weight-loss and diabetes drug semaglutide. The expert explains the potential risks of adjusting doses without medical guidance, including reduced effectiveness and side effects, while noting the limited circumstances where a low dose may genuinely make sense for some patients.

A functional medicine expert has cautioned that high-dose GLP-1 weight-loss drugs such as Ozempic may affect more than appetite and food cravings, suggesting possible broader disruptions to the body that are not yet fully understood. The warning comes as GLP-1 medications continue to surge in popularity for weight loss, with many users reporting unexpected side effects.

The FDA has announced a new nationwide recall of a blood pressure medication, prompting the agency to urge patients taking the affected product to check their supply and consult their doctor or pharmacist. Further details, including the manufacturer, specific lot numbers, and the reason for the recall, have not been reported.

New research reported by SciTechDaily suggests that losing the same amount of weight does not produce identical health benefits for everyone. The findings point to individual variation in how the body responds to weight loss, meaning two people with the same result may see different improvements in metabolic or cardiovascular health. The story is drawing attention for challenging the assumption that weight loss alone reliably translates into uniform health gains.

Minnesota Vikings star wide receiver Justin Jefferson has been ruled out for the game against the Tampa Bay Buccaneers due to an ankle injury. His absence is a significant blow to Minnesota's offence, as Jefferson is one of the NFL's top playmakers. Fans and analysts are watching closely for updates on how long he may be sidelined.

A forum letter in Singapore's The Straits Times argues that patients who combine Western medicine with traditional Chinese medicine should be guided by professional judgment rather than outright prohibitions. The writer says blanket bans ignore real patient behaviour, and that doctors should instead assess interactions and advise patients openly on how to use both systems safely.

A South China Morning Post piece examines the risks of combining traditional Chinese medicine with Western prescription drugs, warning that interactions between herbal remedies and pharmaceuticals can reduce drug effectiveness or cause harmful side effects. The article urges patients to tell their doctors about any herbal treatments they use, as these are often undisclosed and can interact with common medications.

Josh Allen and the Buffalo Bills beat the Los Angeles Chargers 24-16 despite committing five turnovers. The win came despite sloppy play on offense, with the Bills surviving repeated giveaways that would typically prove costly. Buffalo's defense and key plays proved enough to hold off Los Angeles and secure the result.

Disc Medicine (IRON) is under scrutiny following an FDA setback and the disclosure of legal investigations, prompting investors to question whether the biotech stock is now undervalued. Coverage focuses on whether the share price already reflects the regulatory disappointment and litigation risks, or whether further downside remains for shareholders.